Growth Metrics

Edwards Lifesciences (EW) Minority Interest (2023 - 2025)

Edwards Lifesciences has reported Minority Interest over the past 3 years, most recently at $61.2 million for Q2 2025.

  • For Q2 2025, Minority Interest fell 8.93% year-over-year to $61.2 million; the TTM value through Jun 2025 reached $61.2 million, down 8.93%, while the annual FY2024 figure was $64.5 million, 7.06% down from the prior year.
  • Minority Interest for Q2 2025 was $61.2 million at Edwards Lifesciences, down from $62.9 million in the prior quarter.
  • Over five years, Minority Interest peaked at $84.0 million in Q1 2023 and troughed at $61.2 million in Q2 2025.
  • A 3-year average of $68.4 million and a median of $67.8 million in 2024 define the central range for Minority Interest.
  • On a YoY basis, Minority Interest climbed as much as 5.08% in 2024 and fell as far as 18.45% in 2024.
  • Year by year, Minority Interest stood at $69.4 million in 2023, then decreased by 7.06% to $64.5 million in 2024, then fell by 5.12% to $61.2 million in 2025.
  • Business Quant data shows Minority Interest for EW at $61.2 million in Q2 2025, $62.9 million in Q1 2025, and $64.5 million in Q4 2024.